SER-214
SER-214 Ia
Phase 1 small_molecule active
Quick answer
SER-214 for Parkinson's Disease is a Phase 1 program (small_molecule) at Serina Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Serina Therapeutics
- Indication
- Parkinson's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active